Effect of LY3314814 on the Pharmacokinetics of Dabigatran in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 24 Mar 2018
At a glance
- Drugs Lanabecestat (Primary) ; Dabigatran etexilate
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 24 Mar 2018 Results presented at the 119th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
- 25 Jan 2016 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 23 Dec 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.